World's Best Scientists 2026 revealed!
Fernando C. Fervenza

Fernando C. Fervenza

D-Index & Metrics

Medicine

D-Index
103
Citations
44293
World Ranking
7293
National Ranking
3819

Overview

Fernando C. Fervenza is a researcher affiliated with the Mayo Clinic in the United States, specializing in the field of medicine, with a primary focus on nephrology. Their scholarly contributions are mainly concentrated in renal diseases and glomerulopathies, vasculitis and related conditions, as well as chronic kidney disease and diabetes. Other significant topics addressed in their work include coagulation, bradykinin, polyphosphates, and angioedema, amyloidosis diagnosis and treatment, complement system in diseases, and autoimmune bullous skin diseases.

Fervenza has authored numerous publications, notably appearing in prominent nephrology and renal medicine journals. Frequent publication venues include:

  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Kidney International
  • Nephrology Dialysis Transplantation
  • Clinical Journal of the American Society of Nephrology

Their recent notable papers include:

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases, 2021, Kidney International
  • Membranous nephropathy, 2021, Nature Reviews Disease Primers
  • The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis, 2020, Nature Communications
  • Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients, 2020, Kidney International

Fernando C. Fervenza collaborates frequently with several researchers, reflecting a diverse network of academic partnerships. Their frequent co-authors include:

  • Sanjeev Sethi
  • Ladan Zand
  • Ulrich Specks
  • Samih H. Nasr
  • Marta Casal Moura

Their research spans multiple subfields such as pulmonary and respiratory medicine, genetics, molecular biology, and pathology and forensic medicine, contributing broadly to interdisciplinary medical sciences. This multidisciplinary approach complements their primary focus on nephrology and related renal pathologies.

Best Publications

  • Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis

    John H. Stone;Peter A. Merkel;Robert Spiera;Philip Seo

  • Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study†

    Brad H. Rovin;Richard Furie;Kevin Latinis;R. John Looney

  • KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility

    Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers

  • Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis

    Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu

  • Efficacy of Remission-Induction Regimens for ANCA-associated Vasculitis

    Ulrich Specks;Peter A. Merkel;Philip Seo;Robert Spiera

  • Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

  • C3 glomerulopathy: consensus report

    Matthew C. Pickering;Vivette D. D'agati;Carla M. Nester;Richard J. Smith

  • Membranoproliferative Glomerulonephritis — A New Look at an Old Entity

    Sanjeev Sethi;Fernando C. Fervenza

  • Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.

    Laurence H. Beck;Fernando Custodio Fervenza;David M. Beck;Ramon G B Bonegio

  • Rituximab for Refractory Wegener's Granulomatosis: Report of a Prospective, Open-Label Pilot Trial

    Karina A. Keogh;Steven R. Ytterberg;Fernando C. Fervenza;Kimberly A. Carlson

  • Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases.

    Brad H. Rovin;Sharon G. Adler;Jonathan Barratt;Frank Bridoux

  • The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group.

    Nelson Leung;Frank Bridoux;Vecihi Batuman;Aristeidis Chaidos

  • Diagnosis of monoclonal gammopathy of renal significance

    Frank Bridoux;Nelson Leung;Colin A. Hutchison;Guy Touchard

  • Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

    Fernando C. Fervenza;Gerald B. Appel;Sean J. Barbour;Brad H. Rovin

  • Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy

    Ulrich Specks;Fernando C. Fervenza;Thomas J. McDonald;Marie C. E. Hogan

  • C3 glomerulonephritis: Clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

    Sanjeev Sethi;Fernando C. Fervenza;Yuzhou Zhang;Ladan Zand

  • The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification Working Group of the International IgA Nephropathy Network and the Renal Pathology Society:

    Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally

  • ATYPICAL HEMOLYTIC UREMIC SYNDROME AND C3 GLOMERULOPATHY: CONCLUSIONS FROM A «KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES» (KDIGO) CONTROVERSIES CONFERENCE

    Timothy H.J. Goodship;H. Terence Cook;Fadi Fakhouri;Fernando C. Fervenza

Frequent Co-Authors

Sanjeev Sethi
Sanjeev Sethi Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
Ulrich Specks
Ulrich Specks Mayo Clinic
Samih H. Nasr
Samih H. Nasr Mayo Clinic
John H. Stone
John H. Stone Harvard University
Richard J.H. Smith
Richard J.H. Smith University of Iowa
Daniel C. Cattran
Daniel C. Cattran University Health Network
E. William St. Clair
E. William St. Clair Duke University
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens up a wide range of related online degree options and alternative pathways. For those interested in nursing but concerned about exam requirements, there are nursing schools that don't require teas test, making entry more accessible for some prospective students.

If leadership and management in healthcare appeal to you, consider enrolling in an accelerated healthcare administration degree online. These programs are designed for those who wish to quickly advance into administrative or managerial roles within healthcare systems.

For licensed nurses aiming to become nurse practitioners, ASN holders can explore tailored bridge programs, such as an asn to np degree pathway. This route helps streamline the process of earning an MSN and expanding clinical capabilities.

Nutrition and food science are also promising fields, especially with flexible learning options. Discover the best online food science degree programs to find opportunities in research, public health, or the food industry.

Best Scientists Citing Fernando C. Fervenza

Trending Scientists